ADITXT, INC. (ADTX) SEC News June 23, 2026, 20:22 UTC (99% Neutral) ADITXT, INC. (ADTX) Announces Regulatory Update Full text
Register to leave comments News bot June 23, 2026, 8:26 p.m. 📋 ADITXT, INC. (ADTX) - Regulatory Update Filing Date: 2026-06-23 Accepted: 2026-06-23 16:22:16 Event Type: Regulatory Update Event Details: ADITXT, INC. (ADTX) Announces Regulatory Update ADITXT, INC. (ADTX) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development: 🔬 Clinical Development Pipeline (ADITXT, INC.): Product Type Development Stage Therapeutic Area Source Laboratory assessment of antibody profiles Other Preclinical COVID-19 ClinicalTrials.gov 💼 Business Developments: PartnershipAcquisition: Not availableLicensing: Not availableRegulatory Approval: Not availableExecutive Changes: Not available Structured Data: Company Name: ADITXT, INC.Ticker Symbol: ADTX
📋 ADITXT, INC. (ADTX) - Regulatory Update
Filing Date: 2026-06-23
Accepted: 2026-06-23 16:22:16
Event Type: Regulatory Update
Event Details:
🔬 Clinical Development Pipeline (ADITXT, INC.):
💼 Business Developments:
Structured Data: